Home/Filings/4/0001683168-25-000023
4//SEC Filing

Salkind Gene 4

Accession 0001683168-25-000023

CIK 0001084267other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 4:05 PM ET

Size

7.4 KB

Accession

0001683168-25-000023

Insider Transaction Report

Form 4
Period: 2024-12-30
Salkind Gene
Director10% Owner
Transactions
  • Exercise of In-Money

    Convertible notes

    2024-12-30210,000411,544 total
    Exercise: $0.50From: 2024-07-25Exp: 2024-12-31Common Stock (420,000 underlying)
  • Exercise of In-Money

    Common Stock

    2024-12-30$0.50/sh+420,000$210,0008,643,695 total
Footnotes (3)
  • [F1]Not applicable.
  • [F2]The securities listed in Table I and Table II are securities owned directly by Dr. Salkind and his wife and by a family trust.
  • [F3]Includes (i) 59,211 shares underlying warrants exercisable at $60 per share, (ii) 2,333 shares underlying options exercisable at $68.48 per share, (iii) 100,000 shares underlying options exercisable at $.20 per share and (v) options to purchase 250,000 shares exercisable at $2.45 per share.

Documents

1 file

Issuer

Mobiquity Technologies, Inc.

CIK 0001084267

Entity typeother

Related Parties

1
  • filerCIK 0001592481

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:05 PM ET
Size
7.4 KB